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Histoplasmosis, a systemic fungal disease caused by Histoplasma capsulatum var. capsulatum (15) , is an important health problem worldwide. Although the majority of cases present as a mild to moderate flu-like disease requiring only supportive therapy, approximately 5% of patients develop a more serious pulmonary and extrapulmonary disease that can be life-threatening if diagnosis is delayed or if treatment is not initiated rapidly. Histoplasmosis is most prevalent in the midwestern states of the United States (27) (28) (29) (30) , although smaller regions of endemicity are scattered throughout most of Latin America (17, 22, 24) . The disease is one of the most common systemic mycoses in Brazil, where epidemiological surveys carried out by use of the histoplasmin skin test indicate that this mycosis is endemic in all areas surveyed (9) . These data suggest that the numbers of cases of histoplasmosis in Brazil may be underestimated and that the areas of endemicity are more widespread than previously thought.
The diagnosis of histoplasmosis is based on the results of clinical evaluation, culture of the organism, and various laboratory tests. Isolation and culture of H. capsulatum var. capsulatum provide a definitive diagnosis (15, 30) , although complement fixation and precipitin tests that detect antibodies against the major serodiagnostic marker (the M antigen) play a significant role in the identification of infection (10, 11, 18, (33) (34) (35) (36) .
The Histoplasma urine antigen test is also useful, particularly in cases of disseminated disease (31) . However, serodiagnostic methods have limitations associated with false positivity, which arises from the presence of cross-reactive epitopes shared with other fungal pathogens.
At present, our group is focusing attention on the M glycoprotein because it is an immunodominant antigen that is responsible for the first precipitins to arise in acute-phase histoplasmosis; it is also commonly present in all phases of disease (11, 18, 19) . The purification and evaluation of this molecule as a possible tool in the diagnosis of histoplasmosis were reported previously (33) (34) (35) , together with the cloning, characterization, and expression of the gene encoding the M antigen (36) . It was found that the sequence of the gene for the M antigen demonstrated significant homology to those of genes for other fungal catalases (8, 10, 23, 36) ; this discovery in turn raised the possibility that specific peptide sequences of the M-protein gene could be mapped by computational analysis. In the present study, four oligonucleotide primers whose sequences were based on regions of the M gene with little or no homology with the genes for other fungal catalases were designed for use in a PCR for the detection and identification of H. capsulatum var. capsulatum. Primer design. Oligonucleotide primers were designed on the basis of the nucleotide sequence of the M antigen from H. capsulatum var. capsulatum deposited in GenBank (accession no. AFO26268) after comparison with the sequences of other catalases from eukaryotes. Alignments were made with the FASTA program (version 3). Table 1 includes the primer sequences, the positions of the primers in the open reading frame of the gene, and the predicted sizes of the amplified products.
MATERIALS AND METHODS

Microorganisms
PCR assay. PCR was performed with 100 ng of extracted DNA amplified in a 25-l reaction volume consisting of PCR buffer (10 mM Tris-HCl, 50 mM KCl), 1.5 mM MgCl 2 , 200 M deoxynucleoside triphosphates, 2.5 U of Taq DNA polymerase (Gibco BRL, Grand Island, N.Y.), and 20 pmol of each primer. Thirty-five cycles of repeated denaturation, primer annealing, and enzymatic chain extension were performed in a 2400 Thermal Cycler (Perkin-Elmer Applied Biosystems, Foster City, Calif.). The amplification program was carried out as follows: 95°C for 5 min, 1 min at 95°C, 1 min at 70°C, and 1 min at 72°C, followed by a single terminal extension at 72°C for 5 min. An internal PCR control was used in all amplifications to verify the efficiency of the test and to ensure that PCR inhibition was absent. The universal fungal primers ITS1 and ITS4, derived from highly conserved regions of the fungal rRNA gene, were used for this purpose (32) .
PCR was carried out with serially diluted DNA extracted from H. capsulatum var. capsulatum strain F-182 (100 ng to 1 pg) to determine the analytical sensitivity of the test.
Electrophoresis. The PCR products were electrophoresed through 1% agarose (Sigma Chemical Co., St. Louis, Mo.) dissolved in Tris-borate-EDTA buffer (0.1 M Tris, 0.09 M boric acid, 0.001 M EDTA [pH 8.4]). Electrophoresis was conducted at 80 V for 60 min, with 5 l of each PCR amplicon plus 1 l of tracking dye added to each well; the bands were visualized with a UV transilluminator after ethidium bromide staining.
Nucleotide sequence analysis. The products amplified by PCR were purified with the QIAquick PCR purification kit (Qiagen Inc., Valencia, Calif.). The nucleotide sequences were determined with an automated sequencer (PerkinElmer Applied Biosystems) according to the instructions of the manufacturer.
RESULTS
The PCR system with the two specific primer pairs was specific for H. capsulatum var. capsulatum regardless of where the fungus was isolated (Table 2) . Primer set Msp1F-Msp1R and primer set Msp2F-Msp2R amplified the predicted products of 111 and 279 bp, respectively, from all DNA templates obtained from 31 H. capsulatum var. capsulatum isolates studied, even those that had atypical morphologies and/or that were exoantigen negative (strains 16070, 90628, and 90652). The test displayed 100% sensitivity (Fig. 1) , and it was able to amplify the predicted amplicons from as little as 1 ng of DNA (results not shown). Nucleotide sequence analysis of the amplicons revealed the corrected sequences of the H. capsulatum var. capsulatum M-antigen gene. The amplification of the rRNA gene produced a 600-bp amplicon for all fungi tested. These results demonstrate that the specific DNA targets were suitably amplified and ensured that PCR inhibition was absent.
When DNA from H. capsulatum var. duboisii was used as the template, identical PCR products were amplified with both primer sets. However, no DNA fragments were obtained when H. capsulatum var. farciminosum was used in the reaction mixture (Fig. 1) .
For specificity testing, 31 strains of 12 fungal species were examined (Table 3) . No target DNA products were amplified when DNAs from the phylogenetically related pathogens Paracoccidioides brasiliensis, C. immitis, and B. dermatitidis or the unrelated fungi Candida albicans, Candida parapsilosis, Candida tropicalis, Candida krusei, Candida glabrata, S. schenckii, C. neoformans, Aspergillus niger, and Aspergillus fumigatus were tested with primers Msp1F-Msp1R and Msp2F-Msp2R.
DISCUSSION
The detection of H. capsulatum infections is still largely dependent on culture of the organism from material taken from the patient; once the organism is in culture, precise identification relies on visualization of the typical morphology and the demonstration of dimorphism. Identification of the fungal species grown in cultures of clinical specimens is essential for appropriate clinical decision making and the monitoring of antifungal therapy. Unfortunately, saprophobic fungi such as members of the genera Chrysosporium, Corynascus, Renispora, and Sepedonium produce structures which resemble the tuberculated macroconidia of H. capsulatum var. capsulatum, making visual identification difficult. In addition, many laboratories, particularly those in developing countries, do not have direct access to trained mycologists capable of confirming a visual identification. The use of thermal dimorphism for identification may also be problematic since conversion to the yeast phase in vitro is strain dependent, and the process may take up to 4 weeks (30) .
This report describes a one-step PCR assay for the detection and identification of DNA sequences from the gene encoding capsulatum isolates tested in the study, including those incompletely distinguished by morphological and exoantigen tests, were correctly identified. Thus, H. capsulatum var. capsulatum 90628 and 90652 did not convert at 37°C, did not yield macroconidia and microconidia after 2 months of cultivation, and did not produce exoantigen; however, both were PCR positive. The same was true of H. capsulatum var. capsulatum 16070, which also did not yield the characteristic morphology when it was grown at 25 and 37°C (although it was exoantigen positive). The presence of a unique band as a product of amplification has been considered a positive result for PCR with specific primers (1) . A single band of 1.0 pg was amplified from target H. capsulatum var. capsulatum DNA with the specific primers Msp1F-Msp1R and Msp2F-Msp2R, and sequencing confirmed the identities of the predicted 111-and 279-bp products, so validating the sensitivity and specificity of this test. Both primer pairs were equally effective, which confirms that the approach taken was suitably robust. Certainly, the sensitivity of the test described in this report compares favorably with that of a previously disclosed assay, which had a sensitivity of 1.0 pg when primers Pm1 and Pm2 were used in a single PCR amplification for the rapid identification of Penicillium marneffei (26 whether clinical or environmental, had no impact on the sensitivity of detection, which proves the utility of the primers selected for PCR assay. The specificity of this assay was demonstrated by the fact that no specific band was amplified when the DNAs of other pathogenic fungal species were used as the DNA template. Thus, for example, the absence of any amplification product from Candida species demonstrates that this one-step PCR test can be used to avoid the false detection of such potentially saprophytic fungi. Recently, applications have been developed to apply nested PCR assays in the detection of H. capsulatum var. capsulatum in cultures of clinical and environmental isolates (4, 5, 6, 21) . These studies were accomplished with either a single-copy gene (4) or ribosomal genes (21) . A PCR assay targeting the rRNA genes has the ability to achieve a higher sensitivity. However, the conserved nature of rRNA genes may cause nonspecific amplification (3) . Nested PCR has several inherent problems including contamination during the manipulation and nonspecific amplification. The latter was demonstrated by Bialek and coworkers (2, 6) , who found that even the high stringency of their nested PCR could not prevent nonspecific amplification. Methods to detect multiple fungal species (20, 25) have included a PCR-enzyme immunoassay which could detect H. capsulatum var. capsulatum (16) . However, that test requires the use of multiple heterologous probes, and in addition, the production of minor hybridization signals among taxonomically related fungi is a problem. The technological complexity of this methodology may make it unsuitable for use in less well equipped centers.
The system of DNA detection described here could be expanded to detect individual varieties within species of the genus Histoplasma. Thus, one band was also observed when the H. capsulatum var. duboisii template was evaluated by this test. Although this variety is distinct from H. capsulatum var. capsulatum in term of its epidemiology, clinical manifestations, and the morphology of the yeast phase, isolates of H. capsulatum var. duboisii can be sexually crossed with H. capsulatum var. capsulatum (13) . These fungi are classified as a single biological species, in which the two varieties share a specific mate recognition system (14) . Surprisingly, amplification did not occur when the DNA template consisted of H. capsulatum var. farciminosum DNA. The latter causes subcutaneous and ulcerated lesions of the skin only in horses and mules (15 In conclusion, the PCR assay described in this report, which was developed with specific primers pairs whose sequences were based on the H. capsulatum var. capsulatum M-protein gene sequence, proved to be a sensitive and specific test for the identification of typical and atypical isolates of this fungal species. This methodology has obvious applications in the identification of H. capsulatum var. capsulatum strains cultured from clinical samples, and studies are in progress to determine its application to the diagnosis of histoplasmosis in a diagnostic laboratory setting. This study also represents the first step toward determining whether this test has applicability to the direct detection of H. capsulatum var. capsulatum in clinical samples such as blood or tissue; future work will be targeted toward this goal. 
